Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Medical Data Vision Co Ltd (3902)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
583.0 -4.0    -0.68%
26/04 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 143,000
  • Bid/Ask: 582.0 / 585.0
  • Day's Range: 576.0 - 587.0
Type:  Equity
Market:  Japan
ISIN:  JP3921250001 
Medical Data Vision 583.0 -4.0 -0.68%

3902 Balance Sheet

 
Featured here, the Balance Sheet for Medical Data Vision Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 4662 3986 3873 3534
Cash and Short Term Investments 3218 2862 3007 2488
Cash - - - -
Cash & Equivalents 3218 2862 3007 2488
Short Term Investments - - - -
Total Receivables, Net 1103 769 560 782
Accounts Receivables - Trade, Net 1103 769 560 782
Total Inventory 6 5 3 5
Prepaid Expenses - - - -
Other Current Assets, Total 335 350 303 259
Total Assets 6221 5571 5586 5196
Property/Plant/Equipment, Total - Net 158 129 141 137
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 89 217 230 243
Intangibles, Net 1 1 2 2
Long Term Investments 965 1237 1338 1278
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 1 2 2
Other Assets, Total -418 -414 -254 -518
Total Current Liabilities 1805 1462 1674 1448
Accounts Payable 140 104 132 143
Payable/Accrued - - - -
Accrued Expenses 5 12 15 10
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 1660 1346 1527 1295
Total Liabilities 1905 1548 1760 1533
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest 65 92 89 92
Other Liabilities, Total 35 -6 -3 -7
Total Equity 4316 4023 3826 3663
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 992 992 992 992
Additional Paid-In Capital 1838 1838 1838 1838
Retained Earnings (Accumulated Deficit) 3795 3475 3261 3091
Treasury Stock - Common -2341 -2341 -2341 -2341
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 32 59 76 83
Total Liabilities & Shareholders' Equity 6221 5571 5586 5196
Total Common Shares Outstanding 38.2 38.2 38.2 38.2
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

3902 Comments

Write your thoughts about Medical Data Vision Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email